Interventional Cardiology & Surgery
Latest News
Maternal Serum Folate Levels During Pregnancy Linked to Congenital Heart Disease Risk
A U-shaped association was found between maternal serum folate levels and CHD risk in offspring, with both low and high levels linked to increased...
Latest News
‘Shed the Lead’ and the Injuries. Should Cath Labs Go Lead-Free?
Cardiologists may experience injuries from long-term wear of lead aprons, but new technology means they can lose the gear.
Commentary
Old, Frail Patients: Study More, Intervene Less?
The greatest challenge for the cardiologist of today is not a lack of treatment options, but whether we should use all options in older, frailer...
Latest News
Do Cannabis Users Need More Anesthesia During Surgery?
Although the 0.04 difference in minimum alveolar concentration of anesthetics between cannabis users and nonusers was statistically significant,...
Latest News
Not Kidding: Yellow Dye 5 May Lead to Invisibility
Study found that yellow dye led to temporarily transparent skin in mice, making vessels, muscle, and organs visible.
Latest News
Cell Phone Use Linked to Higher Heart Disease Risk
Study links cell phone calls, at least weekly, sleep disruption, and physicological distress to heart disease.
Latest News
Skip Potassium After Cardiac Surgery
Postoperative atrial fibrillation risks is not altered with potassium supplementation for patients who recently had CV surgery, says study.
Latest News
FDA ‘Recalls’ Often Leave Targeted Medical Devices in Use
Recent FDA “recalls” of medical devices actually issue corrections to instructions rather than removal from use.
Latest News
Less Invasive, Overlooked Option in Cardiac Surgery May Offer Benefit
Sutureless valves are an alternative to SAVR and TAVR, but are used less often and have less data.
Latest News
Trial of Impella Heart Pump Stopped
After another trial of the heart pump showed better survival, RECOVER IV trial was halted.
Commentary
Why Cardiac Biomarkers Don’t Help Predict Heart Disease
Physician discusses recent study findings that cardiac biomarkers will not likely help risk-stratify patients.